Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk.

Autophagy and phagocytosis are two important endogenous lysosomal dependent clearing systems in the organism. In some neurological disorders, excessive autophagy or dysfunctional phagocytosis has been shown to contribute to brain injury. Recent studies have revealed that there are underlying interactions between these two processes. However, different studies show inconsistent results for the contribution of autophagy to the phagocytic process in diverse phagocytes and relatively little is known about the link between them especially in the brain. It is critical to understand the role that autophagy plays in phagocytic process in order to promote the clearance of endogenous and exogenous detrimental materials. In this review, we highlight the studies focusing on phagocytosis and autophagy occurring in the brain and summarizing the possible regulatory roles of autophagy in the process of phagocytosis. Balancing the roles of autophagy and phagocytosis may be a promising therapeutic strategy for the treatment of some neurological diseases in the future. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

INTRODUCTION

Autophagy and phagocytosis are two highly conserved endogenous lysosomal dependent clearing processes with similar morphological characteristics and functions. Both processes can form transient vesicular structures (autophagosomes and phagosomes, respectively) that engulf and deliver cargo to the lysosomes for digestion [1]. In addition, they are important in the maintenance of cellular and tissue homeostasis through degrading detrimental intra- and extra-cellular material [2]. Autophagy is an intracellular homeostatic mechanism whereby cytosolic constituents including aberrant organelles and proteins are delivered to the lysosomes for degradation. Unlike autophagy, phagocytosis comprises of the ingestion of extracellular agents, such as dying cells and pathogens to prevent the spillover of proinflammatory and neurotoxic molecules. However, excessive autophagy or dysfunctional phagocytosis can also exacerbate brain injury under certain pathological conditions [3-5]. Balancing the roles of autophagy and phagocytosis may be important for the treatment of some neurological disorders. Recently more attention has been given to the link between autophagy and phagocytosis [1, 2, 6-8]. Some research results have shown that autophagy can regulate phagocytosis via affecting the expression of target-recognizing receptors, phagosome maturation, and recycling of the phagocytic receptors. However, contrary findings have been reported in different studies about the relationship between these two processes. The nature of the interactions and underlying mechanisms between autophagy and phagocytosis remain unclear. In this review, we will discuss the role of autophagy and phagocytosis in the brain and summarize the recent advances that have been made in exploring the mechanisms underlying the cross-talk between autophagy and phagocytosis in diverse phagocytes. In summary, more experimental studies aiming to better understand the regulatory effect of autophagy on phagocytosis are needed to develop potential therapeutic avenues that can promote the phagocytic clearance of brain-derived pathological cargo in some neurological disorders.

PHAGOCYTOSIS IN THE BRAIN

Mechanism of Phagocytosis

Phagocytosis is the process through which cells recognize, engulf, and digest large particles (>0.5um) [9, 10]. It is a receptor-mediated process consisting of three major steps: “find me”, “eat me”, and “digest me” that eventually results in the removal and elimination of particles including, but not limited to, bacteria, apoptotic cells, neoplastic cells, or cellular debris [10, 11]. Common phagocytes include monocytes, macrophages, microglia, dendritic cells, Langerhans cells, osteoclasts, and so on [12, 13]. Microglia have been regarded as the major phagocytes in the brain [14, 15]. During phagocytosis, self and non-self target particles can be recognized by specific receptors on the plasma membrane, and this recognition relies on coordinated specific engulfment signals [12]. We depict the engulfment of apoptotic cells as an example to elucidate the process of phagocytosis (Fig. ).

First, the apoptotic cells release “find me” signals to attract phagocytes toward them [16]. Some of the most representative “find me” signals include lysophosphatidylcholine (LPC), sphingosine-1-phosphate (S1P), CX3C motif chemokine ligand 1 (CX3CL1), and nucleotides [17]. The signals bind with the corresponding “find me” receptors expressed on the phagocytes to facilitate the migration of macrophages to the apoptotic cells [12, 13, 16-18].

Next, when the macrophages are close enough to the target cells, a set of cell surface molecules expressed on the apoptotic cells can tag these cells as dead. These tags are the so-called “eat me” signals for phagocytosis [13]. Therefore, in the second step the dying cells expose “eat me” signals to be engulfed by macrophages. The most well-known and important “eat me” signal is phosphatidylserine (PtdSer). PtdSer is a type of phospholipid located on the inner membrane leaflet of the lipid bilayer in healthy cells, and when under apoptotic stress, PtdSer will be externalized on the outside cell surface [19]. The exposed PtdSer on apoptotic cell surface is recognized directly by PtdSer receptors (e.g. T cell immunoglobulin and mucin domain containing (Tim) family proteins, Brain-specific angiogenesis inhibitor 1(BAI1), Stabilin-2, CD300f and Receptor for advanced glycation end products (RAGE)) or indirectly by some bridging molecules (e.g. proteinS and C1q) [17]. In addition, Calreticulin (CRT), integrins, immunoglobulins (IgG superfamily), and complement proteins are other important “eat me” signals expressed on the apoptotic cell surface [17, 20]. As for healthy cells, “don’t eat me” signals on the cell surface such as CD47 and CD31 prevent live cells from being phagocytosed. CD47 was found to bind to signal regulatory protein-α(SIRPα) on macrophages to inhibit phagocytosis [13, 21]. It has been reported that there exists a repulsive signal CD31-CD31 homotypic interaction between viable neutrophils and phagocytes, which can mediate detachment of viable cells from phagocytes. However, this repulsive signal does not exist in apoptotic cells [22].

Finally, in the “digest me” stage, phagocytes engulf and completely degrade apoptotic cells in the lysosomal compartment [23]. After receptor-target recognition, complex signaling cascades are elicited leading to cytoskeletal rearrangement of actin filaments (F-actin). Actin polymerization serves as the force driving membrane extension and phagosome formation [12, 17]. The cargo is internalized into single-membrane phagosomes, and then these compartments fuse with lysosome to form the phagolysosome, promoting the cargo degradation [24].

Scavenger Receptors

Scavenger receptors(SRs) are transmembrane glycoproteins that typically bind numerous ligands and promote the clearance of non-self or altered-self targets [11]. They are important in the recognition and internalization of the targets. Based on the sequence similarity or shared structural features, scavenger receptors can be classified into different classes [25-28]. However, there is still a lack of a consensus standardized nomenclature system, which may affect communication and collaboration among investigators. The most studied classes of receptors include the class A, class B and class I scavenger receptors. SR-A1, also called macrophage scavenger receptor 1 (MSR1), is one of the most common class types of A scavenger receptors (SR-A) in macrophages, monocytes, microglia and dendritic cells. It has been found that SR-A1 can bind to β-amyloid (Aβ), heat shock proteins, surface molecules of bacteria, hepatitis C virus, and modified low density lipoprotein (acetylated LDL and oxidized LDL) [29]. The macrophage receptor with collagenous structure (MARCO) is another member of the class A SRs family. The expression level of MARCO in human brain, cultured human astrocytes and rodent microglia is very low. However, it is highly expressed in rodent astrocytes and macrophages [26]. CD36 is one of the most widely studied class B SRs expressed in monocytes, endothelial cells, and microglia. CD36 plays an important role in the recognition and endocytic uptake of erythrocytes, thrombospondin, collagen, lipids, fatty acids, apoptotic cells and amyloid proteins [30-32]. CD163 is the prototype class I scavenger receptor for haptoglobin-hemoglobin (Hp-Hb) complexes [25, 31]. In addition, high levels of CD163 is a feature of macrophages undergoing differentiation toward the “alternatively activated” M2 phenotype [27].

Detection of Phagocytosis

Quantifying phagocytosis is critical for understanding its contribution to pathophysiological process of various diseases. Multiple in vitro and in vivo techniques have been applied to study phagocytosis. Flow cytometry and microscopy are frequently used to assess the uptake by cells in vitro of fluorescently-labeled synthetic or physiological particles (e.g. latex, Aβ, myelin, zymosan or dextran) [10, 33, 34]. In one of the studies, the phagocytosis of erythrocytes by microglia was detected by 5(6)-carboxyfluorescein diacetate-labeled red blood cells (RBCs) applied to tag the target. The fluorescence intensity of the cell lysate from microglia containing engulfed RBCs can be referred to as phagocytosis index indicating the phagocytic efficacy of microglia [34]. However, the in vitro culture environment of phagocytes is different from the microenvironment in vivo. Furthermore, cultured cells are often used with synthetic phagocytic targets such as latex beads. Performing either in vitro or in vivo phagocytic assays with beads is artificial, as these particles do not release any chemoattractant and therefore cannot promote phagocytosis [35]. Thus in vitro assays may not accurately recapitulate physiological phagocytosis. It has been reported that alternatively activated M2-like microglia promote phagocytosis of RBCs and tissue debris in intracerebral hemorrhage (ICH) rodent model [36]. In addition, M2 microglia also play important roles in phagocytosis and toxicity clearance in other brain diseases, such as ischemic stroke [37, 38], traumatic brain injury (TBI) [39] and epilepsy [40]. In vivo studies have used the ratio of M2/M1 microglia (e.g. CD16, CD86 for M1 markers and CD206, Arginase 1 for M2 markers) to reflect phagocytosis indirectly [36, 41]. However, it might be misleading to use “markers” as a proxy for phagocytosis. Some studies have developed different methodological approaches to directly quantify phagocytosis in vivo, such as 3D electron microscopy reconstruction and live imaging using 2-photon microscopy [42-44]. In one study, researchers suggested that a novel magnetic resonance imaging(MRI) post-processing technique of gradient-recalledecho (GRE), the quantitative susceptibility mapping (QSM), is an accurate and noninvasive method for quantifying brain iron level, reflecting the hematoma clearance indirectly in an ICH Minipig Model [45].

Phagocytosis in Neurological Disorders

Microglia are the major phagocytes in the brain which can engulf and degrade microbes as well as various brain-derived cargo such as apoptotic cells, synapses, myelin and protein deposits such as Aβ and aggregated α-synuclein (α-syn) [12, 46, 47]. Whether microglial phagocytosis plays a beneficial or detrimental role in brain diseases remains controversial although most researchers now are inclined to the former [47]. Numerous studies show that microglia maintain homeostasis and possibly contribute to the neural network by assisting in synaptic remodeling and plasticity [48]. Synaptic pruning is mediated by microglia during neuronal circuit formation in the developing brain [49]. It has been found that efficient clearance of tissue debris is critical in the reconstruction and reorganization of neuronal networking after an injury in the brain [43, 50, 51]. Microglia phagocytosis promoted axon regeneration and microenvironment restoration during the recovery of an acute brain injury [47]. However, microglia have also been found to pathologically phagocytose synapses of neurons with tau pathology in Alzheimer’s disease (AD), which can indirectly lead to more tau-induced synapse loss [49], and the loss of synapses has emerged as a major correlate of cognitive decline in AD recently [52]. Apart from microglia, other phagocytes in the brain can also play a role in the removal of brain-derived cargo [53]. A study showed that monocyte-derived macrophages (MDMs), once localized to the site of injury, have a higher phagocytic capacity than microglia in cerebral ischemic stroke model [54]. In addition, astrocytes can also participate in the elimination of synapses and neuronal debris [10, 14, 15]. Recently, it has been found that phagocytosis by astrocytes can be actuated when microglial phagocytic activity is impaired. Astrocytes express TAM phagocytic receptors (MerTK and AXL),which are the main astrocytic phagocytic receptors for cell debris [55]. Moreover, infiltrated T cells also play an indirect role in regulation of phagocytosis. T cells extravasating into the brain can modulate the adaptive immune makeup in central nervous system (CNS)for not only the clearance of patho-proteins but can also promote the repair of damaged neurons by secreting neurotropic factors [56]. Furthermore, activated microglia enhanced the phagocytosis of degenerating myelin in the presence of infiltrated myelin-reactive T cells possibly through interleukin-2 (IL-2) and interleukin-1 beta (IL-1β) secretion [57, 58].

Phagocytosis and Neurodegenerative Diseases

Some human genetic and experimental studies showed a clear link between impaired microglial phagocytosis and neurodegenerative diseases [12, 59]. Triggering receptor expressed on myeloid cells 2(TREM2), a kind of pattern recognition receptor in the brain with various anionicligands (e.g. phosphatidylethanolamine (PE), phosphatidylserine (PS), cardiolipin (CL), phosphatidic acid (PA)), signals by forming a complex with the co-receptor DNAX-activation protein 12 (DAP12) [60, 61]. TREM2-DAP12 complex induces the activation of the spleen tyrosine kinase (Syk)/ phospholipase C-gamma (PLC-γ)/phosphoinositide 3-kinase (PI3K) signaling pathway, leading to the promotion of microglia phagocytosis [59]. Variants in TREM2 increase the risk for AD [59, 62], and have been associated with Parkinson’s disease (PD) [12]. For animal studies, TREM2-/- AD mice showed diffused amyloid plaques, with amyloid filaments extending outwards, and fewer compact amyloid plaques compared to control AD mice [59]. On the other hand, overexpression of TREM2 reduced amyloid burden and improved cognitive function in AD mice [63]. It has been reported that TREM2 can promote Aβ phagocytosis via activating CCAAT enhancer-binding protein alpha (C/EBPα)-dependent CD36 expression in microglia [64]. In addition, TREM2 has also been demonstrated to be involved in myelin phagocytosis in Multiple Sclerosis(MS) [10]. Furthermore, inhibition of TREM2 increased the severity of experimental autoimmune encephalomyelitis (EAE). TREM2 overexpression was found to be protective, partially caused by effects on clearance of myelin debris [65-67]. Recently, another famous member of TREM family, TREM1, has been reported to facilitate microglial phagocytosis of Aβ [68, 69]. Evidence showed that rs6910730G, an intronic variant of TREM1, reduced the ability of human monocytes for Aβ phagocytosis in a cohort human study [68]. Additionally, knockdown of TREM1 in the brains of APP/PSEN1 mice increased Aβ1-42 levels and total amyloid burden. While selective overexpression of TREM1 on microglia ameliorated Aβ neuropathology and rescued AD-related spatial cognitive dysfunction [68]. The TAM family receptors, MerTK and AXL, which bind PtdSer via the bridging molecules Protein S and Gas6, respectively, was shown to promote myelin phagocytosis in MS [70-72]. In the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced progressive model of PD, neurodegeneration was associated with decreased expression of scavenger receptor Mannose Receptor C-Type1 (MRC1) [46]. Scavenger receptors such as MSR1, CD36, and CD163 have been found to be involved in macrophage activation and increased phagocytosis of Aβ in AD [26, 73].

Phagocytosis and Acute Brain Disorders

Promoting microglia phagocytic clearance of hematoma has been found to be a promising therapeutic target to ameliorate inflammation and improve neurological outcomes after ICH and germinal matrix hemorrhage (GMH) [31, 74-76]. Endogenous scavenger receptors, such as CD36,MSR1, CD163 and low-density lipoprotein receptor related protein-1 (LRP1, also called CD91) have been reported to play important roles in hematoma clearance [77]. In adult hemorrhagic stroke models, activated transcription factors Nrf2 and peroxisome proliferator-activated receptor (PPAR-γ) could upregulate CD163 and CD36 expression, and consequently augmented microglia/macrophage phagocytic clearance of hematoma [77-79]. Hp-Hb complex can be recognized by CD163 receptors in microglia, promoting hemoglobin degradation and anti-inflammatory effects [80, 81]. Similarly, phagocytes expressing CD91 can endocytose the haem-haemopexin complex and dissociate it by lysosomal activity [82, 83]. In addition, the class A scavenger receptors MSR1 and MARCO play key roles in the internalization of damage-associated molecular patterns (DAMPs) by mononuclear phagocytes to resolve inflammation and prevent the exacerbation of ischemic stroke pathologies [84].

AUTOPHAGY IN THE BRAIN

Mechanism of Autophagy

Autophagy is a conserved cellular pathway involved in protein and organelle degradation that delivers cytoplasmic constituents to the lysosomes for degradation [85]. There are three different types of autophagy including macroautophagy, microautophagy, and chaperone-mediated autophagy [86-89]. Macroautophagy, the best characterized form of autophagy in mammalian cells, usually referred to simply as autophagy is mostly the focus in this review. Autophagy relies on the coordinated action of various members of the autophagy-related gene (ATG) protein family, which together underlie the induction and nucleation, elongation and maturation of autophagosome (AP), as well as the fusion of autophagosomes with lysosomes [90]. Autophagy can be induced by nutrient starvation through the inhibition of mammalian target of rapamycin (mTOR), resulting in translocation of mTOR substrate complex consisting of Unc-51-like kinase 1/2(ULK1/2), ATG13, FAK family interacting-protein of 200 kDa (FIP200) and ATG101 from the cytosol to certain domains of the endoplasmic reticulum or closely attached structures [3, 91]. Next, the recruited class III phosphatidylinositol-3-OH kinase (PI(3)K) complex (Beclin-1-Atg14L-Vps34) produces phosphatidylinositol-3-phosphate (PtdIns(3)P), which binds with effectors such as double FYVE-containing protein 1 (DFCP1) and WD-repeat domain phosphoinositide-interacting (WIPI) family proteins [89]. After the formation of phagophore, the membrane expands and envelopes the cargo to promote the maturation of the autophagosome. Next, the autophagosome delivers its cargo to the lysosome to form the autolysosomes for degradation [5, 89].

Microglia Autophagy in Neurological Disorders

Most of the literature have been published on the role of neuronal autophagy in the brain, and few studies have focused on glial autophagy, such as that performed by microglia and astrocytes. It has been reported that autophagy can regulate immune response of macrophages including inflammation and phagocytic functions [1, 91, 92]. However, there are controversial results whether microglia autophagy plays beneficial or detrimental functions under different pathogenic states in the brain. For example, moderate recruitment of autophagy is beneficial in abolishing brain hypoperfusion. However, its overactivity may be detrimental for cell survival [93]. The discrepant effects may depend on the timing and amount of autophagy activation, thus correctly fine tuning of the time and intensity will be important for clinical application [93].

Microglia Autophagy and Neurodegenerative Diseases

One of the pathological characteristics of PD is the presence of Lewy bodies, an eosinophilic cytoplasmic inclusion comprised largely of α-syn fibrils. It has been found that activation of autophagy in BV2 cells can lead to a reduction of α-syn induced pro-inflammation [94]. On the other hand, inhibition of autophagy in microglia caused PD-like symptoms in mice through activating NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome via phosphodiesterase 10A (PDE10A)–cyclic adenosine monophosphate (cAMP) signaling pathway [95]. In an Aβ-induced AD model, microglial autophagy was shown to participate in the degradation of extracellular Aβ fibrils, and the impairment of microglial autophagy resulted in increased inflammation via increasing IL-1β and activating inflammasome [96]. However, another study demonstrated positive correlation between Beclin-1, IL-1β, and Tumor necrosis factor alpha (TNF-α) in the cortex and/or hippocampus of AD mice, suggesting a relationship between inflammatory responses and autophagy [97].

Microglia Autophagy and Acute Brain Disorders

Microglia are activated in response to injury as one of the main drivers of inflammatory responses after neurotrauma [3, 98]. An increase in markers of autophagy has been reported in microglia after TBI, spinal cord injury(SCI), ischemic stroke and ICH in cellular and animal models [99-102]. However, whether autophagy has positive or negative effects on the inflammatory response after acute brain injury remains unclear. Some studies showed that autophagy exerted neurotoxic effects. It has been reported that cerebral ischemia induced-microglia autophagy closely accompanied ischemic neuroinflammation and injury in a permanent middle cerebral artery occlusion (pMCAO) model in mice [103]. And autophagy induced by toll-like receptor 4(TLR4) activation contributed to microglial activation and inflammatory injury in ICH model [104]. A study showed that the autophagy inhibitor 3-methyladenine (3-MA) attenuated white matter injury and improved working memory during chronic cerebral hypoperfusion in mice [105]. While some other studies have reported that autophagy inhibited neuroinflammatory damage, the autophagy activator rapamycin promoted a shift in microglia from M1 to the favorable M2 phenotype and produced anti-inflammatory effects in ischemic stroke and subarachnoid hemorrhage (SAH) models [106, 107].

LINK BETWEEN AUTOPHAGY AND PHAGOCYTOSIS

It has been reported that there potentially exists a link between autophagy and phagocytosis. Many studies have shown that phagocytosis can be regulated by autophagy (Table ). The potential regulatory effects of autophagy over phagocytosis may occur at various steps of the phagocytic cascade, including cargo uptake, phagosomes maturation, fusion with lysosomes and recycling of phagocytic receptors [1].

Microtubule-associated Protein 1 Light Chain 3 (LC3) Associated Phagocytosis

One recently discovered process called LC3-associated phagocytosis (LAP) bridges autophagy and phagocytosis in macrophages and retinal pigment epithelial (RPE) cells, since LC3 is involved in both processes. LAP is generally defined as a novel form of non-canonical autophagy, sometimes regarded as a special type of phagocytosis as well [46, 108, 109]. It is well-known that autophagosome formation involves the recruitment of LC3 from the cytosol to the limiting membrane of the phagophore where it provides a binding site for autophagy cargos and facilitates fusion with lysosomes [110]. LAP is a process activated by TLR signaling and NADPH oxidase (NOX) during phagocytosis of fungal and bacterial pathogens or apoptotic and necrotic cells, resulting in attachment of LC3 to the cytosolic side of the phagosome membrane where it facilitates phagosome maturation [108, 111]. LC3 is recruited to the single-membrane phagosome depending on the activity of autophagy enzymes Beclin-1, ATG5 and ATG7, but not the recruitment of ULK1 [112-114]. It has been reported that Rubicon and NOX2 are uniquely required by LAP, which can help distinguish between LAP and canonical autophagy [111].

The LC3-decorated phagosomes formed in this process, named LAPosomes, show enhanced fusion with lysosomes resulting in enhanced degradation of contained microbes [115]. In addition, LAP has been reported to be required for the daily clearance of ingested material in the RPE which is important for the photoreceptor outer segment (POS) renewal [116, 117].

Although most studies published so far have shown that LAP promotes phagosome maturation, a study in human macrophages observed quite the opposite-LC3 recruitment to zymosan-containing phagosomes was associated with delayed phagosome fusion with the lysosome [118]. Some researches suggest that whether LAP promotes or suppresses phagosome maturation depends on the foreign target and requires function of synaptosomal associated protein of 23 kDa (SNAP23). SNAP23 that is enriched on the phagosome membrane during LAP may be phosphorylated or dephosphorylated, thereby enhancing or inhibiting subsequent phagosome maturation, respectively [119]. Therefore, the influence of LC3 recruitment to phagosomes remains to be further studied.

In addition, it has been reported that LAP is not universally required for the fusion of phagosome with endosomes and lysosomes [24]. However, LC3-decorated phagosomes show enhanced lysosomal fusion, leading to a more effective degradation of their contents compared to LC3-lacking phagosomes [120]. Although few studies have focused on LAP in microglia, some researchers think this process exists in the brain [121, 122]. It has been reported that microglial autophagy associated phagocytosis is essential for the recovery of neuroinflammation in a murine model of MS [123]. Recently, Green DR et al. identified a related but distinct process of LC3-associated endocytosis (LANDO), which plays a protective role in the endocytosis of Aβ involved in AD [124]. It has been found that even in non-phagocytic cells, this process is required for the recycling of several internalized surface receptors to the plasma membrane. LANDO in microglia was shown to facilitate Aβ clearance and mitigate neurodegeneration in a murine model of AD [125].

In summary, LAP is a unique pathway that links signaling during phagocytosis with recruitment of some members of the autophagy machinery. However, the impact of LC3 recruitment to microglial phagocytosis remains to be tested.

Contribution of Autophagy to Phagocytic Efficiency

In addition to LAP, autophagy and phagocytosis may also be intimately reciprocally regulated in macrophages and microglia through other mechanisms. However, how autophagy modulates the efficiency of phagocytosis, such as promoting or inhibiting phagocytosis, is still unclear. Contrary results have been observed in different studies.

Autophagy is Negatively Correlated with Phagocytosis

Some studies showed that activation of autophagy suppressed phagocytosis [126], while inhibition or loss of autophagy could enhance phagocytosis [2, 127]. Lima et al. found that autophagy induction inhibited classical phagocytosis in murine macrophages via a mechanism that does not interfere with particle-receptor interaction [126]. Induction of autophagy did not affect the capacity of macrophages to recognize and bind to particles, even though particle internalization was suppressed [126]. Bonilla et al. demonstrated that the lack of ATG7 in peripheral macrophages increased phagocytic uptake of bacteria, possibly through enhanced expression of class A scavenger receptors MARCO and MSR1 in phagocyte cell surface [2]. Furthermore, an increase in scavenger receptors was observed with increased activity of the nuclear factor E2-related factor 2(Nrf2) resulting from the accumulation of sequestosome 1 (SQSTM1) in ATG7-/- macrophages [2]. In addition, the authors found that ATG3-/-, ATG5-/-, and ATG7-/- Mouse embryonic fibroblasts (MEFs) all had increased surface expression of MARCO and MSR1 and increased ability to internalize M. tuberculosis var. bovis BCG (BCG), suggesting that the observed changes in scavenger receptor expression and phagocytosis in ATG7-/- cells were autophagy dependent and not due to an autophagy-independent role of ATG7 [2]. A similar study recently found that lack of ATG5 in dendritic cells increased the phagocytic uptake of apoptotic tumor cells, possibly through the enhancement of CD36 expression [6]. It has been reported that the absence of phagocytic receptor Draper in glia can lead to a pronounced accumulation of apoptotic neurons in the brain of Drosophila melanogaster. Inactivating autophagy through Target of Rapamycin Complex 1(TORC1) activation or ATG1 inhibition in glia was sufficient to rescue apoptotic cells accumulation as well as neurodegeneration by regulating phagosome maturation [128]. Furthermore, increased Beclin-1 and ATG12 expression was accompanied by decreased MSR1 expression and MSR1 surface abundance in macrophages [11].

Recent studies showed that certain mediators are involved in the cross-talk between autophagy and phagocytosis. Among these factors, TREMs have been linked to the autophagy pathway [129]. One study showed that increased autophagy was detected in TREM2-deficient microglia and in AD patients carrying TREM2 variants, reflecting a negative correlation between phagocytic receptor TREM2 and autophagy [130]. Additionally, several recent studies indicate that the inflammasome NLRP3 and high-mobility group box protein 1 (HMGB1) may act as cross-talk mediators between autophagy and phagocytosis.After knockout of NLRP3 in peritoneal cells (primarily neutrophils), decreased autophagy, augmented phagocytosis and enhanced scavenger receptor MARCO and mannose binding leptin (MBL) expression was observed in a polymicrobial sepsis mice model [131]. Likewise, HMGB1 could inhibit microglia phagocytosis of Aβ in AD [132, 133]. HMGB1 regulates autophagy through interacting with autophagy related protein Beclin-1.The underlying mechanism might be that binding of HMGB1 in the cytoplasm with Beclin-1 promotes dissociation of Beclin-1 from the apoptosis inhibitor bcl-2, and facilitates binding of Beclin-1 and class III inositol 3 kinase (PI3K ClassIII)/ Vsp34 that activates autophagy [134-136]. However, no study to date has simultaneously evaluated the change in autophagy and phagocytosis under the action of HMGB1.

In summary, the papers discussed above indicate the inhibitory effect of autophagy on phagocytosis, and the mechanisms might be associated with the negative regulation of autophagy on the expression of scavenger receptors or maturation of phagosomes. Recently, some researchers proposed a new possible mechanism to explain the negative correlation effect. They think that since the formation of both phagolysosomes and autolysosomes requires involvement of membrane material from the plasma membrane, competitively to use the limited cellular membrane resources may be the reason for negative regulation between autophagy and phagocytosis [11].

Autophagy is Positively Correlated with Phagocytosis

On the other hand, some other research studies show a positive correlation effect of autophagy on the process of phagocytosis. It has been reported that inhibition of autophagy with autophagy inhibitor 3-MA led to reduced phagocytic efficiency in activated macrophages [137, 138]. Inhibiting Beclin-1disrupted phagocytic efficiency by impaired recycling of phagocytic receptor such as CD36 and TREM2 in AD model [139]. In addition, Beclin-1coordinated actin dynamics and membrane phospholipid synthesis to promote efficient apoptotic cell engulfment [140]. The C. elegans Q neuroblasts (Q cells) provide an appealing in vivo model system to understand the roles of autophagy genes in phagocytes for apoptotic cell removal, both apoptotic Q cells and the neighboring phagocyte hyp7 cell can be individually identified using cell type-specific promoters [141, 142]. Autophagy proteins LC3, ATG18 and Ectopic P-Granules Autophagy Protein 5 (EPG-5) acted within the phagocyte to promote apoptotic Q cells degradation, and the engulfment activity was decreased after the loss of autophagy genes ATG18 or EPG-5 [143]. As for the mechanism, ATG18 and EPG-5 loss showed delayed recruitment of lysosomal markers to the internalized apoptotic Q cell corpse. In addition, the recruitment of small guanosine triphosphatases RAB-7 and RAB-5 onto the phagosome was also delayed with ATG18 and EPG-5 loss, which affected phagolysosome formation [143].

In addition, some studies showed positive correlation between autophagy and phagocytosis. For example, TLR4 activation by lipopolysaccharide (LPS) in microglia could suppress autophagy and impair phagocytic capacity of microglia via inhibiting the activation of transcription factor Forkhead box O3 (FOXO3) [121]. Likewise, DJ-1 deficiency impaired autophagy and reduced uptake and clearance of α -syn in the phagocytosis by microglia, while the molecular mechanism remains unclear [144].

These studies indicate that autophagy may have a cytoprotective effect on phagocytosis. It should be noted that both 3-MA and Beclin-1 or LC3 reduction can also inhibit LAP. Of note, many of the pharmacological and gene approaches used in autophagy research may also affect LAP, which could complicate data interpretation [1],and should be taken into consideration when interpreting findings from the studies. Further research is essential to explore whether LAP plays a role in the phagocytosis process of macrophages and microglia.

CONCLUSION AND FUTURE DIRECTIONS

In this review, we focused on the emerging evidence and the roles of autophagy on phagocytosis. Published literature indicates that there are interactions between these two processes. The studies mostly showed that autophagy machinery can regulate engulfment activity of phagocytes through modulating the expression of the scavenger receptors. In this review we highlighted how autophagy can influence phagocytosis. Conversely, phagocytosis machinery might also affect autophagy. The activation of Class A scavenger receptor inhibited endoplasmic reticulum stress-induced autophagy in macrophage [145]. The phagocytic receptor TREM2 promoted the degradation oftype I transmembrane protein TMEM59, whose expression could facilitate autophagic flux through its carboxyl-terminus [146]. However, based on current studies it is unclear whether autophagy is positively or negatively correlated with phagocytosis. Contradictory results from different studies may be due to inconsistent spatial and temporal assessment of inflammation, phagocytic activity and outcomes in various models. In addition, the studies summarized in this review focused on diverse phagocytic cell types, which might also account for the discrepant results. More research is essential to determine whether autophagy can also regulate internalization process, phagosome maturation, fusion with lysosome and recycling of the phagocytic receptors. In addition, most of the studies to date were preliminary observations on how autophagy influences phagocytosis, while little is known about the molecular mechanisms that mediate the effects. Another challenge in the field has been the difficulty in detecting the in vivo phagocytosis process directly in different models. Although some new imaging techniques such as 3D electron microscopy reconstruction and live imaging with 2-photon microscopy have been proposed to observe the engulfment process, the cost effectiveness of these techniques needs may be limiting.

A better understanding of the role of autophagy in phagocytosis is critical, as promoting the phagocytic clearance of brain-derived cargo such as apoptotic cells, Aβ, myelin debris, and hematoma in the brain could be a beneficial therapeutic strategy for many neurological disorders. However, there are currently limited studies published on the interactions between autophagy and phagocytosis in the brain. Future research efforts are needed to study the cross-talk between autophagy and phagocytosis which may provide novel therapeutic avenues.

Table1

Current evidence of the cross-talk between autophagy and phagocytosis.

-	Phagocyte	Disease/Model	Relationship	Mechanism	Refs.
Autophagy is negatively correlated with phagocytosis	In vitro studies
	Macrophages	Infecting macrophages with Mtb or BCG	Myeloid-specific Atg7-/- macrophages exhibited higher Mtb and BCG uptake	Accumulating SQSTM1 activated Nrf2, leading to upregulation of MSR1 and MARCO	[2]
	Dendritic cells	Irradiating live EG7 cells with γ-ray, and then coculturing with BMDCs	Atg5-deficient dendritic cells showed increased phagocytosis of apoptotic tumor cells	Increased expression of scavenger receptor CD36	[6]
	Macrophages	Macrophages were exposed to CFDA-SE-labeled Escherichia coli K-12, CFDA-SE-labeled Lactobacillus reuteri ATCC PTA 6475, orFluoresbrite YG microsphere	Decreased phagocytosis was seen in Hrh2-/- macrophages with increased expression of autophagy genes Beclin-1 and ATG12	Increased Beclin-1 and ATG12 expression was accompanied by decreased MSR1 expression and MSR1 surface abundance in Hrh2-/- macrophages	[11]
	Macrophages	Coculturing heat inactivated yeast particles or L. amazonensis stationary phase promastigotes with macrophages	Autophagy induced by physiological (starvation) and pharmacological (rapamycin) methods was shown to reduce the phagocytic capacity of murine macrophages	Inhibiting particle internalization	[126]
	Macrophages	Infecting RAW264.7 cells with ST239-MRSA	Autophagy inhibitor 3-MA promoted phagocytosis of macrophage	-	[127]
	In vivo studies
	Macrophages	Intranasally infecting mice with BCG	Atg7-/- mice showed increased bacterial loads	-	[2]
	Dendritic cells	Injecting apoptotic tumor cells into the footpads of the indicated mice	Atg5-deficient dendritic cells showed increased phagocytosis of apoptotic tumor cells	Increased expression of scavenger receptor CD36	[6]
	Macrophages	Intranasally inserting ST239-MRSA to establish mouse pneumonia model	Autophagy inhibitor 3-MA protected mice from MRSA pneumonia	-	[127]
	Glia	Knocking down Draper (isoform I) in cortex glia in the brain of Drosophila melanogaster	Inactivating autophagy through TORC1 activation could rescue the accumulation of apoptotic neurons in the brain of Draper-/- deficient Drosophila melanogaster	-	[128]
	Microglia	AD patients carrying TREM2 risk variants; TREM2-deficient mice with AD-like pathology	Increased autophagy was detected inTREM2-deficient microglia and in AD patients carrying TREM2 variants	TREM2 maintained microglia at high metabolic states through enhanced activation of the mTOR pathway	[130]
	Neutrophils	NLRP3-deficient (Nlrp3-/-) mice in polymicrobial sepsis model induced by CLP	HMGB1-/- peritoneal cells (primarily neutrophils) showed decreased autophagy and augmented phagocytosis	-	[131]
Autophagy is positively correlated with phagocytosis	In vitro studies
	Microglia	LPS treated microglia was incubated with Aβ1−42 fibrils	TLR4 activation induced by LPS suppressed autophagy and impaired phagocytic capacity of microglia	-	[121]
	Macrophages	Macrophages were exposed to apoptotic lymphocytes or Jurkat T cells induced by cyclophosphamide	Autophagy inhibitor 3-MA decreased phagocytosis of the apoptotic cells by macrophages	-	[138]
-	Phagocyte	Disease/Model	Relationship	Mechanism	Refs.
	Microglia	Uptake of latex beads for Beclin-1 knockdown BV2 microglial cells	Reducing microglial Beclin-1 levels significantly impaired phagocytosis, and phagocytosis was “rescued” by recovering Beclin-1 levels with a lentivirus encoding mouse Beclin-1	Reduced Beclin-1 disrupted retromer-mediated recycling of phagocytic receptors CD36 and TREM2	[139]
	Microglia	Incubation of DJ-1 deficient microglia with α-syn.	DJ-1 deficiency impaired autophagy and reduced uptake and clearance of α-syn in the phagocytosis in microglia	-	[144]
	In vivo studies
	Microglia	Injecting fibrillar Aβ into the frontal cortex of Beclin-1+/- mice	Reduced microglial Beclin-1 impaired Aβ phagocytosis	-	[139]
	Epithelial hyp7 cell	Apoptotic C. elegans apoptotic Q cells degraded by epithelial an hyp7 cell	Autophagy proteins LC3, ATG-18, EPG-5 act within the phagocyte to promote apoptotic cell degradation	ATG18 and EPG-5loss showed delayed recruitment of RAB-5, RAB-7, and lysosomal markers onto the apoptotic Q cell corpse	[143]

Abbreviations: Mtb: Mycobacterium tuberculosis; BCG: M. tuberculosis var. bovisBCG;MSR1: Macrophage scavenger receptor 1; MARCO: macrophage receptor with collagenous structure; BMDCs: Bone marrow-derived dendritic cells; Hrh2: histamine H2 receptor gene; MRSA: Methicillin-resistant Staphylococcus aureus; TORC1: Target of Rapamycin Complex 1; TREM2: Triggering receptor expressed on myeloid cells 2; mTOR: mammalian target of rapamycin; CLP: cecal ligation and puncture; LPS:lipopolysaccharide; Aβ:β-amyloid; TLR4: Toll-like receptor 4;α-syn: α -synuclein.